Relief in Coldrif Syrup Case

The High Court's decision to grant bail to the Medical Representative of Shrisan Pharma marks a significant development in the Coldrif syrup case. The representative had been in judicial custody for 9 months. The case has been under scrutiny, and this bail is seen as the first major relief. The details of the case are still emerging, but the bail decision is a crucial step forward. The High Court's ruling is expected to have implications for the ongoing investigation.